Skip to content

Clinical trials

Myelodysplastic Syndromes trials in the United States with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Unknown status Country / region: United States Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20041
20052
20062
20073
20081
20091
20101
20121
20134
20152
20173
20181
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Colorado Blood Cancer Institute2
Herbert Irving Comprehensive Cancer Center2
Office of Rare Diseases (ORD)2
PersImmune, Inc2
ALZA1
Arno Therapeutics1
Ascentage Pharma Group Inc.1
Benovus Bio, Inc.1
Celgene Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes34
Leukemia, Myeloid, Acute17
Leukemia12
Precursor Cell Lymphoblastic Leukemia-Lymphoma12
Lymphoma10
Multiple Myeloma8
Leukemia, Lymphocytic, Chronic, B-Cell7
Leukemia, Myeloid, Chronic-Phase7
Lymphoma, Non-Hodgkin7
Blast Crisis6

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.